المؤلفون: Pierre Lebailly, Sandrine Roulland, Gac Ac, Yannick Lecluse, Pascal Gauduchon, Bertrand Nadel

المساهمون: Groupe Régional d'Etudes sur le CANcer ( GRECAN ), Université de Caen Normandie ( UNICAEN ), Normandie Université ( NU ) -Normandie Université ( NU ) -Centre Régional de Lutte contre le Cancer François Baclesse ( CRLC François Baclesse ) -IFR146, Centre Régional de Lutte contre le Cancer François Baclesse ( CRLC François Baclesse ), Centre d'Immunologie de Marseille - Luminy ( CIML ), Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Groupe Régional d'Etudes sur le CANcer (GRECAN), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-IFR146, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Centre d'Immunologie de Marseille - Luminy (CIML), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-IFR146, Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2009, 23 (6), pp.1190-3. 〈10.1038/leu.2009.31〉
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2009, 23 (6), pp.1190-3. ⟨10.1038/leu.2009.31⟩
Leukemia, 2009, 23 (6), pp.1190-3. ⟨10.1038/leu.2009.31⟩

مصطلحات موضوعية: Male, Cancer Research, Translocation, Genetic, 0302 clinical medicine, MESH : Translocation, Genetic, Long period, [ SDV.IMM ] Life Sciences [q-bio]/Immunology, ComputingMilieux_MISCELLANEOUS, 0303 health sciences, MESH: Middle Aged, MESH : Chromosomes, Human, Pair 14, MESH : Chromosomes, Human, Pair 11, food and beverages, Hematology, Middle Aged, MESH : Adult, MESH: Translocation, Genetic, 3. Good health, Cell Transformation, Neoplastic, Oncology, 030220 oncology & carcinogenesis, Healthy individuals, [SDV.IMM]Life Sciences [q-bio]/Immunology, Adult, MESH : Male, Biology, 03 medical and health sciences, mental disorders, Humans, MESH : Middle Aged, 030304 developmental biology, Chromosomes, Human, Pair 14, Blood Cells, MESH: Humans, Chromosomes, Human, Pair 11, MESH: Blood Cells, fungi, MESH: Clone Cells, MESH : Humans, MESH : Clone Cells, MESH: Adult, MESH : Cell Transformation, Neoplastic, Peripheral blood, MESH: Male, Clone Cells, MESH: Cell Transformation, Neoplastic, Immunology, MESH : Blood Cells, MESH: Chromosomes, Human, Pair 14, MESH: Chromosomes, Human, Pair 11

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5709e76881bebc21bb76d20c60cedf5
https://hal.archives-ouvertes.fr/hal-00407785

المؤلفون: Evenden P; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Vandoolaeghe Q; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Lecluse Y; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Gac AC; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Delépée R; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Weiswald LB; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Boutet-Robinet E; Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France., Boulanger M; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Bonassi S; Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy.; Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Rome, Italy., Lebailly P; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France., Meryet-Figuière M; Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, Caen, France. m.meryet-figuiere@baclesse.unicancer.fr.; Comprehensive Cancer Center François Baclesse, UNICANCER, Caen, France. m.meryet-figuiere@baclesse.unicancer.fr.

المصدر: International archives of occupational and environmental health [Int Arch Occup Environ Health] 2024 May; Vol. 97 (4), pp. 353-363. Date of Electronic Publication: 2024 Mar 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7512134 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1246 (Electronic) Linking ISSN: 03400131 NLM ISO Abbreviation: Int Arch Occup Environ Health Subsets: MEDLINE

مواضيع طبية MeSH: Leukocytes, Mononuclear* , Occupational Exposure*/adverse effects, Female ; Humans ; Animals ; Cattle ; Swine ; Comet Assay ; Farmers ; DNA Damage ; Agriculture

المؤلفون: Ghesquières H; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Krzisch D; Department of Hematology, Assistance Publique Hopitaux de Paris, Hopital Saint Louis, Paris, France., Nicolas-Virelizier E; Department of Hematology, Centre Leon Berard, Claude Bernard Lyon 1 University, Lyon, France., Kanoun S; Department of Hematology, Cancer Research Center of Toulouse, Team 9, INSERM Unité Mixte de Recherche 1037, Toulouse, France., Gac AC; Department of Hematology, Institut d'Hematologie de Basse Normandie, Caen, France., Guidez S; Hematology Department, Centre Hospitalier Universitaire, Poitiers, France., Touati M; Department of Hematology, Hôpital Dupuytren, Centre Hospitalier Universitaire, Limoges, France., Laribi K; Hematology Department, Centre Hospitalier, Le Mans, France., Morschhauser F; Department of Hematology, Centre Hospitalier Universitaire Lille, Universite de Lille, ULR 7365 Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Bonnet C; Department of Hematology, University Hospital Liege, Liege, Belgium., Waultier-Rascalou A; Hematology of Department, Centre Hospitalier Universitaire, Nimes, France., Orsini-Piocelle F; Department of Hematology, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France., André M; Department of Hematology, Centre Hospitalier Universitaire, Université Catholique de Louvain Namur, Université Catholique de Louvain, Yvoir, Belgium., Fournier M; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France., Morand F; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France., Berriolo-Riedinger A; Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France., Burroni B; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France., Damotte D; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France., Traverse-Glehen A; Department of Pathology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Quittet P; Department of Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Casasnovas O; Department of Hematology, University Hospital F. Mitterrand and INSERM Unité Mixte de Recherche 1231, Dijon, France.

المصدر: Blood [Blood] 2024 Mar 14; Vol. 143 (11), pp. 983-995.

نوع المنشور: Multicenter Study; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/pathology, Humans ; Aged ; Middle Aged ; Aged, 80 and over ; Vinblastine/adverse effects ; Prednisone/adverse effects ; Bendamustine Hydrochloride/adverse effects ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Doxorubicin/adverse effects ; Cyclophosphamide ; Vincristine

المؤلفون: Chantepie SP; Institut d'hématologie de Basse-Normandie, CHU Caen, France. Electronic address: chantepie-s@chu-caen.fr., Mear JB; Service d'hématologie, CHU Rennes, France., Briant AR; Unité de Biostatistique et Recherche Clinique, CHU Caen, France., Vilque JP; Institut d'hématologie de Basse-Normandie, Centre François Baclesse, France., Gac AC; Institut d'hématologie de Basse-Normandie, CHU Caen, France., Cheze S; Institut d'hématologie de Basse-Normandie, CHU Caen, France., Girault S; Service d'hématologie, CHU Limoges, France., Turlure P; Service d'hématologie, CHU Limoges, France., Marolleau JP; Service d'hématologie, CHU Amiens, France., Lebon D; Service d'hématologie, CHU Amiens, France., Charbonnier A; Service d'hématologie, CHU Amiens, France., Jardin F; Service d'hématologie, Centre Henri Becquerel, Rouen, France., Lenain P; Service d'hématologie, Centre Henri Becquerel, Rouen, France., Peyro-Saint-Paul L; Département de recherche clinique, CHU Caen, France., Abonnet V; Institut d'hématologie de Basse-Normandie, CHU Caen, France., Dutheil JJ; Département de recherche clinique, CHU Caen, France., Chene Y; Département de recherche clinique, CHU Caen, France., Bazin A; Unité d'Hémovigilance, CHU Caen, France., Reman O; Institut d'hématologie de Basse-Normandie, CHU Caen, France., Parienti JJ; Département de biostatistique et de recherche clinique, service d'infectiologie, CHU Caen, France.

المصدر: Leukemia research [Leuk Res] 2023 Jun; Vol. 129, pp. 107058. Date of Electronic Publication: 2023 Mar 18.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Diseases* , Leukemia, Myeloid, Acute*/etiology, Humans ; Retrospective Studies ; Erythrocyte Transfusion/adverse effects ; Hemoglobins ; Acute Disease

المؤلفون: Fornecker LM; Institut de Cancérologie Strasbourg Europe (ICANS) and University of Strasbourg, Strasbourg, France., Lazarovici J; Gustave Roussy, Villejuif, France., Aurer I; University Hospital Centre Zagreb, Zagreb, Croatia., Casasnovas RO; University Hospital F Mitterrand, Dijon, France., Gac AC; Institut d'hématologie de Basse-Normandie, Caen, France., Bonnet C; CHU Liège, Liège, Belgium., Bouabdallah K; University Hospital of Bordeaux, Bordeaux, France., Feugier P; University Hospital of Nancy and University of Lorraine, Vandoeuvre les Nancy, France., Specht L; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Molina L; University Hospital Grenoble Alpes, Grenoble, France., Touati M; CHU Limoges, Limoges, France., Borel C; IUCT-Oncopole, CHU Toulouse, Toulouse, France., Stamatoullas A; Centre H Becquerel, Rouen, France., Nicolas-Virelizier E; Centre L Bérard, Lyon, France., Pascal L; Hôpital Saint Vincent de Paul, Lille, France., Lugtenburg P; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Di Renzo N; Presidio Ospedaliero Vito Fazzi, Lecce, Italy., Vander Borght T; CHU UCL Namur, Yvoir, Belgium., Traverse-Glehen A; Hospices Civils de Lyon and Université Lyon 1, Lyon, France., Dartigues P; Gustave Roussy, Villejuif, France., Hutchings M; Rigshospitalet, Copenhagen, Denmark., Versari A; Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Meignan M; LYSA Imaging and University Paris Est Créteil, Créteil, France., Federico M; University of Modena and Reggio Emilia, Modena, Italy., André M; CHU UCL Namur, Yvoir, Belgium.

مؤلفون مشاركون: LYSA-FIL-EORTC Intergroup

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 10; Vol. 41 (2), pp. 327-335. Date of Electronic Publication: 2022 Jul 22.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology, Humans ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Brentuximab Vedotin ; Bleomycin ; Vinblastine ; Doxorubicin ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dacarbazine ; Neoplasm Staging ; Treatment Outcome

المؤلفون: Stamatoullas A; Département d'Hématologie, Centre Henri Becquerel, Rouen, France., Ghesquières H; Département d'Hématologie, Centre Hospitalier Lyon Sud, Lyon France., Feugier P; Département d'Hématologie, CHU Nancy, Nancy, France., André M; Département d'Hématologie, CHU UCL, Namur, Belgique., Le Bras F; Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France., Gac AC; Département d'Hématologie, CHU, Caen, France., Borel C; Département d'Hématologie, IUCT Oncopole, Toulouse, France., Gastinne T; Département d'Hématologie, CHU Nantes, Nantes, France., Quittet P; Département d'Hématologie, CHU Montpellier, Montpellier, France., Morschhauser F; Département d'Hématologie, CHRU Lille, Lille, France., Ribrag V; Département of Hématologie, Institut Gustave Roussy, Paris, France., Guidez S; Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, Poitiers, France., Nicolas-Virelizier E; Service d'Hématologie, Centre Léon Bérard, Lyon, France., Berriolo-Riedinger A; Service de Médecine Nucléaire, Centre GF Leclerc, Dijon, France., Vander Borght T; Service de médecine Nucléaire, CHU UCL Namur, Namur, Belgique., Edeline V; Service de Médecine Nucléaire, Institut Curie, Hôpital R Huguenin, Saint-Cloud, France., Brice P; Département d'Hématologie, Hôpital Saint Louis, APHP Paris, Paris, France.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3063-3071. Date of Electronic Publication: 2022 Aug 17.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Hodgkin Disease*/drug therapy , Lymphoma*/drug therapy , Neoplasm Recurrence, Local*/drug therapy, Humans ; Brentuximab Vedotin/therapeutic use ; Carboplatin/therapeutic use ; Etoposide/therapeutic use ; Ifosfamide/therapeutic use ; Immunoconjugates/therapeutic use ; Treatment Outcome

المؤلفون: Rossi C; Department of Hematology, Dijon-Bourgogne University Hospital, Dijon; INSERM unit 1231, University of Burgundy Franche-Comté, France. cedric.rossi66@gmail.com., André M; Department of Hematology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium., Dupuis J; Lymphoid Malignancies Unit, Henri Mondor University Hospital (AP-HP), Créteil, France., Morschhauser F; Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA), Department of Haematology, CHU Lille, Université de Lille, Lille., Joly B; Department of Hematology, Hospital Sud Francilien, Corbeille-Essonnes, France., Lazarovici J; Department of Hematology, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Ghesquières H; Department of Hematology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre-Bénite, France., Stamatoullas A; Department of Hematology, Centre Henri Becquerel, Rouen, France., Nicolas-Virelizier E; Department of Hematology, Centre Léon Bérard, Lyon, France., Feugier P; Hospital of Nancy, Vandoeuvre les Nancy, France., Gac AC; Department of Haematology, Institut d'hématologie de Basse Normandie, Caen, France., Moatti H; Department of Hematology, CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Saint-Louis, Paris, France., Fornecker LM; Department of Haematology, University Hospital of Strasbourg, Strasbourg, France., Deau B; Department of Hematology, CHU Cochin, Paris, France., Joubert C; Lymphoma Academic Research Organisation, CHU Lyon-Sud, Lyon, France., Fortpied C; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Raemaekers J; Department of Haematology, Radboud University Medical Center, Nijmegen, Netherlands., Federico M; CHIMOMO department, University of Modena and Reggio Emilia, Policlinico, Modena, Italy., Kanoun S; Nuclear Medecine Unit, Institut universitaire du cancer Toulouse-Oncopole, Toulouse, France., Meignan M; LYSA Imaging, University Hospital H Mondor, Creteil, France., Traverse-Glehen A; Department of Pathology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre- Bénite, France., Cottereau AS; Nuclear Medecine Department, Hôpital Cochin, AP-HP, Université de Paris, France., Casasnova RO; Department of Hematology, Dijon-Bourgogne University Hospital, Dijon; INSERM unit 1231, University of Burgundy Franche-Comté, France.

المصدر: Haematologica [Haematologica] 2022 Dec 01; Vol. 107 (12), pp. 2897-2904. Date of Electronic Publication: 2022 Dec 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/drug therapy, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bleomycin ; Dacarbazine/therapeutic use ; Doxorubicin/therapeutic use ; Prognosis ; Risk Factors ; Tumor Burden ; Vinblastine ; Clinical Trials, Phase III as Topic ; Randomized Controlled Trials as Topic

المؤلفون: Nguyen A; Department of Internal Medicine and Clinical Immunology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., Martin-Silva N; Department of Internal Medicine and Clinical Immunology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., de Boysson H; Department of Internal Medicine and Clinical Immunology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., Deshayes S; Department of Internal Medicine and Clinical Immunology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., Gac AC; Department of Clinical Haematology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., Reboursière E; Department of Clinical Haematology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., Damaj G; Department of Clinical Haematology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France., Aouba A; Department of Internal Medicine and Clinical Immunology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France.

المصدر: Swiss medical weekly [Swiss Med Wkly] 2022 Jun 06; Vol. 152, pp. w30143. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Trägerverein Swiss Medical Weekly SMW Country of Publication: Switzerland NLM ID: 100970884 Publication Model: eCollection Cited Medium: Internet ISSN: 1424-3997 (Electronic) Linking ISSN: 00367672 NLM ISO Abbreviation: Swiss Med Wkly Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/pathology, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/therapeutic use ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Retrospective Studies ; gamma-Globulins/therapeutic use

المؤلفون: Casasnovas RO; Department of Hematology, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France., Bouabdallah R; Department of Hematology, Institut P. Calmette, Marseille, France.; Department of Hematology, Hopital privé de Provence, Aix en Provence, France., Brice P; Department of Hematology, APHP, Hopital Saint Louis, Paris, France., Lazarovici J; Department of Hematology, Institut G. Roussy, Villejuif, France., Ghesquieres H; Department of Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, et Université Claude Bernard Lyon-1, Pierre Bénite, France., Stamatoullas A; Department of Hematology, Centre H. Becquerel, Rouen, France., Dupuis J; Lymphoid Malignancies Unit, Henri Mondor University Hospital, Créteil, France., Gac AC; Department of Hematology, Institut d'hématologie de basse normandie, Caen, France., Gastinne T; Department of Hematology, University Hospital of Nantes, Nantes, France., Joly B; Department of Hematology, Hospital Sud Francilien, Corbeille-Essonnes, France., Bouabdallah K; Department of Hematology, University Hospital of Bordeaux, Bordeaux, France., Nicolas-Virelizier E; Department of Hematology, Centre L. Bérard, Lyon, France., Feugier P; Department of Hematology, University Hospital of Nancy, Vandoeuvre les Nancy, France., Morschhauser F; Department of Hematology, CHU Lille, Unité GRITA, Université de Lille 2, Lille, France., Sibon D; Department of Hematology, Hopital Necker, Paris, France., Bonnet C; Department of Hematology, University Hospital Liege, Liege, Belgium., Berriolo-Riedinger A; Department of Nuclear Medicine, Centre G.F. Leclerc, Dijon, France., Edeline V; Department of Nuclear Medicine, Hopital R. Huguenin, Institut Curie, St-Cloud, France., Parrens M; Department of Pathology, University Hospital of Bordeaux and Inserm UMR 1053, Bordeaux, France., Damotte D; Department of Pathology, Université de Paris et GH Paris Centre APHP, Paris, France., Coso D; Department of Hematology, Institut P. Calmette, Marseille, France., André M; Department of Hematology, CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium.; Pole Mont, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium., Meignan M; Department of Nuclear Medicine, University Hospital H. Mondor, Creteil, France., Rossi C; Department of Hematology, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Apr 01; Vol. 40 (10), pp. 1091-1101. Date of Electronic Publication: 2022 Jan 06.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/drug therapy , Neoplasms, Second Primary*/pathology, Adolescent ; Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bleomycin ; Cyclophosphamide ; Dacarbazine ; Doxorubicin ; Etoposide ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Staging ; Positron-Emission Tomography/methods ; Prednisone ; Procarbazine ; Vinblastine ; Vincristine ; Young Adult

المؤلفون: Faudemer J; Nuclear Medicine Department, Caen University Hospital, Caen, France., Aide N; Nuclear Medicine Department, Caen University Hospital, Caen, France.; UNICAEN, INSERM 1086 ANTICIPE, Normandy University, Caen, France., Gac AC; Haematology Institute, Caen University Hospital, Caen, France., Damaj G; Haematology Institute, Caen University Hospital, Caen, France., Vilque JP; Haematology Institute, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France., Lasnon C; UNICAEN, INSERM 1086 ANTICIPE, Normandy University, Caen, France. c.lasnon@baclesse.unicancer.fr.; Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, 3 Avenue du General Harris, BP 45026, 14076, Caen Cedex 5, France. c.lasnon@baclesse.unicancer.fr.

المصدر: Scientific reports [Sci Rep] 2021 Dec 10; Vol. 11 (1), pp. 23812. Date of Electronic Publication: 2021 Dec 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Fluorodeoxyglucose F18* , Positron Emission Tomography Computed Tomography*/methods, Bone and Bones/*diagnostic imaging , Lymphoma, Follicular/*diagnosis, Aged ; Biomarkers ; Combined Modality Therapy ; Female ; Humans ; Lymphoma, Follicular/mortality ; Lymphoma, Follicular/therapy ; Male ; Middle Aged ; Positron-Emission Tomography ; Prognosis ; ROC Curve ; Treatment Outcome